Atomy Root Vital Shampoo is listed in Korea as a 500 mL functional cosmetic that helps alleviate hair-loss symptoms. That category is not the same as a medicine that treats hair loss, and it does not promise new hair growth for every user.
Korea’s Ministry of Food and Drug Safety has specifically warned against advertising this cosmetic category as though it provides medicinal hair-growth effects. Its consumer guidance distinguishes symptom-alleviation cosmetics from choosing treatment with a qualified professional.
Separate the product category from a personal diagnosis
The listing can tell you the product’s intended category, ingredients, size and directions. It cannot determine the cause of a particular person’s hair changes or give an individual date by which an outcome will occur.
If hair loss or scalp changes are concerning you, get appropriate professional advice. A purchase should not substitute for finding out whether a problem needs assessment or treatment.
Read the satisfaction figure with its question
Atomy’s page presents testing involving 22 participants, conducted by P&K Skin Research Center from March 20 to April 18, 2024. It includes satisfaction questions about features such as foam, fragrance and root volume.
A 100% response for a stated question concerns that participant group and that question. It is not a 100% probability of treating every type of hair loss in the general population.
| Information | What to keep attached to it |
|---|---|
| Satisfaction percentage | The exact question participants answered |
| Participant count | The size of that study group |
| Measured change | What was measured, over what period and under which conditions |
| Individual expectation | Not established merely by the headline percentage |
A pleasant cleansing experience and treatment of an underlying condition are different outcomes. Keeping those outcomes separate makes the product easier to evaluate without adding a promise it cannot support.
Sources and scope
The Korean product page was checked September 7, 2026. The MFDS item is dated March 18, 2019; it is cited for the cosmetic-versus-treatment distinction, not as a current enforcement finding about this Atomy product.